| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b07e07ae7918451a573516faeaf0a08f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 |
| filingDate |
2019-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_200e84adf99f8e2e7f050f870eb67c6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea898d166119fcd11332f1274417cf91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cddc6ed7a6f062380c67f55001e4d52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1649c4d6d083b2facf27cfeb2abeec0d |
| publicationDate |
2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2019201946-B2 |
| titleOfInvention |
Implants with controlled drug delivery features and methods of using same |
| abstract |
Disclosed herein are drug delivery devices and methods for the treatment of ocular ndisorders requiring targeted and controlled administration of a drug to an interior portion of nthe eye for reduction or prevention of symptoms of the disorder. The devices are capable of ncontrolled release of one or more drugs and may also include structures which allow for ntreatment of increased intraocular pressure by permitting aqueous humor to flow out of the nanterior chamber of the eye through the device.n30/70 nLO nLX)O n0 co ncoo nUlU) ncco |
| priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |